The emergence of nanotherapeutics is attributable to the integration of nanotechnology, recombinant DNA technology, and synthetic organic chemistry with medicine for treating critical human diseases in a more efficient and specific molecular approach than therapy with conventionally-designed and formulated drugs. Nanotherapeutics: From Laboratory t

chapter 13|34 pages

Nanomedicine in clinical trials

chapter 14|34 pages

Approved and commercialized nanomedicine